Pulse of the Industry for healthcare in India
Abstract
Industries development has revolutionized healthcare globally. Although it has many positive contributions but negative impacts are also troubling the human population. They are essential for developing and delivering medical services and products. Through innovation and technology, they provide medical devices, information, pharmaceutical and biotechnology products. Industries also galvanized economic development by jobs, healthcare delivery infrastructure and its management. Health care is the prevention and treatment of illness or disability, encompassing a range of services aimed at maintaining health and addressing medical needs.
Problems with the industries are their inherent characteristics of exploitation of natural resources, creating pollution, causing labour health and safety concerns, producing tobacco, ultra-processed foods, and sugary drinks, prioritize profit over public well-being, and industrialization of healthcare. Industries have to focus on its limitations beside generating innovative safe products and addressing public health issues. Industries are engines of innovation and growth, yet they can perpetuate harm by exploiting natural resources, polluting the environment, marketing unhealthy products like tobacco, ultra-processed foods and sugary drinks, and commercializing healthcare. For industries to be true partners in health, they must adopt responsible innovation, prioritize sustainability, align with sustainable Development Goals (SDGs), and strengthen corporate social responsibility.
References
Bagcchi, S. India has low doctor to patient ratio, study finds. BMJ. 2015; h5195. https://doi.org/10.1136/bmj.h5195
Fang Z, Rossato SL, Hang D, Khandpur N, Wang K, Lo CH, Willett WC, Giovannucci EL, Song M. Association of ultra-processed food consumption with all cause and cause specific mortality: population-based cohort study. BMJ. 2024 May 8;385:e078476. doi: 10.1136/bmj-2023-078476.
Govt of India. About Pradhan Mantri Jan Arogya Yojana (PM-JAY). https://nha.gov.in/PM-JAY (accessed on 27.8.2025).
Hsu PD, Lander ES, Zhang F. "Development and applications of CRISPR-Cas9 for genome engineering". Cell. 2014; 157 (6): 1262–1278. doi:10.1016/j.cell.2014.05.010
Karan, A., Negandhi, H., Hussain, S. et al. Size, composition and distribution of health workforce in India: why, and where to invest?. Hum Resour Health 19, 39 (2021). https://doi.org/10.1186/s12960-021-00575-2
Selvaraj S, Farooqui HH, Karan A. Quantifying the financial burden of households’ out-of-pocket payments on medicines in India: a repeated cross-sectional analysis of National Sample Survey data, 1994–2014. BMJ Open 2018;8:e018020. doi: 10.1136/bmjopen-2017-018020.
Sulis, G., Sayood, S., & Gandra, S. (2021). Antimicrobial resistance in low- and middle-income countries: current status and future directions. Expert Review of Anti-Infective Therapy, 20(2), 147–160. https://doi.org/10.1080/14787210.2021.1951705
WHO. Comprehensive mental health action plan 2013–2030. Geneva: World Health Organization; 2021.
Copyright (c) 2025 International Journal of Preventive, Curative & Community Medicine (E-ISSN: 2454-325X)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.